Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
Clinical trial NCT04578639 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04578639
- Sponsor
- Haukeland University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2025-08-14
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.